American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 25356969.
- Also identified by DOI 10.1038/gim.2014.146.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Huntington disease is an autosomal-dominant neurodegenerative disease of mid-life onset caused by expansion of a polymorphic trinucleotide (CAG) repeat. Variable penetrance for alleles carrying 36-39 repeats has been noted, but the disease appears fully penetrant when the repeat numbers are >40. An abnormal CAG repeat may expand, contract, or be stably transmitted when passed from parent to child. Assays used to diagnose Huntington disease must be optimized to ensure the accurate and unambiguous quantitation of CAG repeat length. This document provides an overview of Huntington disease and methodological considerations for Huntington disease testing. Examples of laboratory reports are also included.
Medical subject headings
- Adolescent
- Adult
- Alleles
- Base Sequence
- DNA Primers
- DNA Primers/genetics
- Genetic Association Studies
- Genetic Predisposition to Disease
- Genetics, Medical
- Genetics, Medical/standards
- Genomics
- Genomics/standards
- Humans
- Huntington Disease
- Huntington Disease/diagnosis
- Huntington Disease/genetics
- Molecular Sequence Data
- Penetrance
- Polymerase Chain Reaction
- Prenatal Diagnosis
- Prenatal Diagnosis/methods
- Prevalence
- Societies, Medical
- Trinucleotide Repeat Expansion
- Trinucleotide Repeats
- United States
- Young Adult